Donepezil Hydrochloride
- Product NDC
- 0615-7842
- 11-digit product format
- 006157842
- Labeler code
- 0615
- Product ID
- 0615-7842_fa9aef3f-7b23-4e91-9328-3ddf51ed4f35
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Donepezil Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA090686
- Marketing category
- ANDA
- Marketing start
- 2011-05-28
- Marketing end
- 0000-00-00
- Substance
- DONEPEZIL HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7842-05 | 2021-05-07 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |
| 0615-7842-30 | 2021-05-07 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |
| 0615-7842-39 | 2021-05-07 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |
| 0615-7842-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |
| 0615-7842-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |
| 0615-7842-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-711d-f424-e053-dadaa90a57ce | 576927b2-394e-40d6-a9ba-150faad629f7 |